HbA1c and Risks of All-Cause and Cause-Specific Death in Subjects without Known Diabetes: A Dose-Response Meta-Analysis of Prospective Cohort Studies
Comment: The traditional clinical focus on hemoglobin A1c (HbA1c) often assumes a benign risk profile until the formal 6.5% diabetic threshold is reached, which is something we in the Naturopathic world know to not be true. This dose-response meta-analysis dismantles that assumption, identifying that every 1% increase in HbA1c is associated with a 3% increase […]
